Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2064

1.

Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib.

Yamamura Y, Matsumoto Y, Asano Y, Katayama Y, Hayashi K, Ohashi K, Morishita M, Watanabe H, Takano-Narazaki M, Sada KE, Wada J.

Rheumatol Adv Pract. 2019 Dec 23;4(1):rkz050. doi: 10.1093/rap/rkz050. eCollection 2020. No abstract available.

2.

Splenic mass of uncertain etiology in a 15-year-old male patient: a case report.

Hisamura M, Mitsui D, Kawaguchi Y, Oshio S, Asano Y, Kameda S, Nakamura M, Chida S, Suzuki M, Koshimizu K.

Acute Med Surg. 2019 Oct 28;7(1):e464. doi: 10.1002/ams2.464. eCollection 2020 Jan-Dec.

3.

Serum delta-like 4 levels: A possible association with interstitial lung disease in systemic sclerosis.

Fukui Y, Miyagawa T, Toyama S, Omatsu J, Hirabayashi M, Nakamura K, Yoshizaki A, Sato S, Asano Y.

J Dermatol. 2020 Jan 26. doi: 10.1111/1346-8138.15245. [Epub ahead of print] No abstract available.

PMID:
31984546
4.

Impact of functional studies on exome sequence variant interpretation in early-onset cardiac conduction system diseases.

Hayashi K, Teramoto R, Nomura A, Asano Y, Beerens M, Kurata Y, Kobayashi I, Fujino N, Furusho H, Sakata K, Onoue K, Chiang DY, Kiviniemi TO, Buys E, Sips P, Burch ML, Zhao Y, Kelly AE, Namura M, Kita Y, Tsuchiya T, Kaku B, Oe K, Takeda Y, Konno T, Inoue M, Fujita T, Kato T, Funada A, Tada H, Hodatsu A, Nakanishi C, Sakamoto Y, Tsuda T, Nagata Y, Tanaka Y, Okada H, Usuda K, Cui S, Saito Y, MacRae CA, Takashima S, Yamagishi M, Kawashiri MA, Takamura M.

Cardiovasc Res. 2020 Jan 24. pii: cvaa010. doi: 10.1093/cvr/cvaa010. [Epub ahead of print]

PMID:
31977013
5.

Effects of cavitation on Kármán vortex behind circular-cylinder arrays: A molecular dynamics study.

Asano Y, Watanabe H, Noguchi H.

J Chem Phys. 2020 Jan 21;152(3):034501. doi: 10.1063/1.5138212.

PMID:
31968948
6.

Wound, pressure ulcer and burn guidelines - 4: Guidelines for the management of connective tissue disease/vasculitis-associated skin ulcers.

Fujimoto M, Asai J, Asano Y, Ishii T, Iwata Y, Kawakami T, Kodera M, Abe M, Amano M, Ikegami R, Isei T, Isogai Z, Ito T, Inoue Y, Irisawa R, Ohtsuka M, Omoto Y, Kato H, Kadono T, Kaneko S, Kanoh H, Kawaguchi M, Kukino R, Kono T, Koga M, Sakai K, Sakurai E, Sarayama Y, Shintani Y, Tanioka M, Tanizaki H, Tsujita J, Doi N, Nakanishi T, Hashimoto A, Hasegawa M, Hayashi M, Hirosaki K, Fujita H, Fujiwara H, Maekawa T, Matsuo K, Madokoro N, Motegi SI, Yatsushiro H, Yamasaki O, Yoshino Y, Pavoux AJL, Tachibana T, Ihn H; Japanese Dermatological Association Guidelines.

J Dermatol. 2020 Jan 21. doi: 10.1111/1346-8138.15186. [Epub ahead of print]

PMID:
31960490
7.

Regulation of skin fibrosis by RALDH1-producing dermal dendritic cells via retinoic acid-mediated regulatory T cell induction: A role in scleroderma.

Miura S, Asano Y, Saigusa R, Yamashita T, Taniguchi T, Takahashi T, Ichimura Y, Toyama T, Yoshizaki A, Sato S, Kadono T.

J Dermatol Sci. 2020 Jan 15. pii: S0923-1811(20)30002-5. doi: 10.1016/j.jdermsci.2020.01.002. [Epub ahead of print]

PMID:
31959382
8.

Increased Expression of Delta-like Ligand 4 in Mycosis Fungoides.

Boki H, Miyagaki T, Shono Y, Kamijo H, Oka T, Suga H, Asano Y, Sugaya M, Sato S.

Acta Derm Venereol. 2020 Jan 13. doi: 10.2340/00015555-3402. [Epub ahead of print]

9.

Damage accrual related to pregnancies before and after diagnosis of systemic lupus erythematosus: a cross-sectional and nested case-control analysis from a lupus registry.

Morishita M, Sada KE, Ohashi K, Miyawaki Y, Asano Y, Hayashi K, Asano SH, Yamamura Y, Watanabe H, Narazaki M, Matsumoto Y, Kawabata T, Yajima N, Wada J.

Lupus. 2020 Feb;29(2):176-181. doi: 10.1177/0961203319898766. Epub 2020 Jan 10.

PMID:
31924143
10.

In vivo real-time ATP imaging in zebrafish hearts reveals G0s2 induces ischemic tolerance.

Kioka H, Kato H, Fujita T, Asano Y, Shintani Y, Yamazaki S, Tsukamoto O, Imamura H, Kogo M, Kitakaze M, Sakata Y, Takashima S.

FASEB J. 2020 Feb;34(2):2041-2054. doi: 10.1096/fj.201901686R. Epub 2020 Jan 8.

PMID:
31916304
11.

Higd1a improves respiratory function in the models of mitochondrial disorder.

Nagao T, Shintani Y, Hayashi T, Kioka H, Kato H, Nishida Y, Yamazaki S, Tsukamoto O, Yashirogi S, Yazawa I, Asano Y, Shinzawa-Itoh K, Imamura H, Suzuki T, Suzuki T, Goto YI, Takashima S.

FASEB J. 2020 Jan;34(1):1859-1871. doi: 10.1096/fj.201800389R. Epub 2019 Dec 10.

PMID:
31914602
12.

Tumoral calcinosis in systemic lupus erythematosus associated with fat necrosis.

Sakakibara M, Yamada D, Toyama S, Funamizu K, Omatsu J, Takahashi-Shishido N, Sato S, Asano Y.

J Dermatol. 2019 Dec 22. doi: 10.1111/1346-8138.15199. [Epub ahead of print] No abstract available.

PMID:
31867787
13.

Rationally-based therapeutic disease modification in systemic sclerosis: Novel strategies.

Asano Y, Varga J.

Semin Cell Dev Biol. 2019 Dec 16. pii: S1084-9521(18)30269-6. doi: 10.1016/j.semcdb.2019.12.007. [Epub ahead of print] Review.

PMID:
31859147
14.

Multiple Sclerosis Exacerbation Associated With High-Altitude Climbing Exposure.

Hsieh CDT, Warden LCGI, Butler MJM, Nakanishi E, Asano Y.

Mil Med. 2019 Dec 11. pii: usz421. doi: 10.1093/milmed/usz421. [Epub ahead of print]

PMID:
31825081
15.

Anomalous Nonlocal Conductance as a Fingerprint of Chiral Majorana Edge States.

Ikegaya S, Asano Y, Manske D.

Phys Rev Lett. 2019 Nov 15;123(20):207002. doi: 10.1103/PhysRevLett.123.207002.

PMID:
31809124
16.

A case of concurrent psoriasis and ulcerative colitis with development of arthritis during adalimumab treatment.

Toyama S, Kanda H, Tateishi S, Yamada A, Sato S, Asano Y.

Eur J Dermatol. 2019 Dec 1;29(6):651-653. doi: 10.1684/ejd.2019.3657. No abstract available.

PMID:
31806587
17.

Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis.

Miyagawa T, Taniguchi T, Saigusa R, Fukayama M, Takahashi T, Yamashita T, Hirabayashi M, Miura S, Nakamura K, Yoshizaki A, Sato S, Asano Y.

Rheumatology (Oxford). 2019 Nov 29. pii: kez517. doi: 10.1093/rheumatology/kez517. [Epub ahead of print]

PMID:
31782787
18.

Concurrence of polyarteritis nodosa and multiple sclerosis.

Matsuda KM, Koguchi A, Toyama T, Sakuishi K, Kobayashi M, Miura S, Miyazaki M, Suga H, Asano Y, Toda T, Sato S.

J Eur Acad Dermatol Venereol. 2019 Nov 25. doi: 10.1111/jdv.16107. [Epub ahead of print] No abstract available.

PMID:
31769115
19.

Loss of ARPC1B impairs cytotoxic T lymphocyte maintenance and cytolytic activity.

Randzavola LO, Strege K, Juzans M, Asano Y, Stinchcombe JC, Gawden-Bone CM, Seaman MN, Kuijpers TW, Griffiths GM.

J Clin Invest. 2019 Dec 2;129(12):5600-5614. doi: 10.1172/JCI129388.

20.

Quality of Life and Emotional Distress in Peritoneal Dialysis and Hemodialysis Patients.

Hiramatsu T, Okumura S, Asano Y, Mabuchi M, Iguchi D, Furuta S.

Ther Apher Dial. 2019 Oct 31. doi: 10.1111/1744-9987.13450. [Epub ahead of print]

PMID:
31671240
21.

Evaluation of the positional relationship between femoral arteries and distal screws in the proximal femoral intramedullary nail for preventing iatrogenic vascular injury.

Asano Y, Yamauchi D, Gonoji Y.

Injury. 2020 Feb;51(2):384-388. doi: 10.1016/j.injury.2019.10.003. Epub 2019 Oct 3.

PMID:
31668355
22.

Localized scleroderma manifesting with skin lesions associated with mechanical stress.

Toyama S, Sato S, Asano Y.

Eur J Dermatol. 2019 Aug 1;29(4):439-440. doi: 10.1684/ejd.2019.3601. No abstract available.

PMID:
31625924
23.

Identification of Novel, Potent, and Orally Available GCN2 Inhibitors with Type I Half Binding Mode.

Fujimoto J, Kurasawa O, Takagi T, Liu X, Banno H, Kojima T, Asano Y, Nakamura A, Nambu T, Hata A, Ishii T, Sameshima T, Debori Y, Miyamoto M, Klein MG, Tjhen R, Sang BC, Levin I, Lane SW, Snell GP, Li K, Kefala G, Hoffman ID, Ding SC, Cary DR, Mizojiri R.

ACS Med Chem Lett. 2019 Sep 19;10(10):1498-1503. doi: 10.1021/acsmedchemlett.9b00400. eCollection 2019 Oct 10.

PMID:
31620240
24.

Adenoid Cystic Carcinoma of the Breast: A Case Report.

Kashiwagi S, Asano Y, Ishihara S, Morisaki T, Takashima T, Tanaka S, Amano R, Ohsawa M, Hirakawa K, Ohira M.

Case Rep Oncol. 2019 Sep 17;12(3):698-703. doi: 10.1159/000502949. eCollection 2019 Sep-Dec.

25.

Clinical Evaluation of Dynamic Monitoring of Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratios in Primary Endocrine Therapy for Advanced Breast Cancer.

Takada K, Kashiwagi S, Asano Y, Goto W, Takahashi K, Shibutani M, Amano R, Takashima T, Tomita S, Hirakawa K, Ohira M.

Anticancer Res. 2019 Oct;39(10):5581-5588. doi: 10.21873/anticanres.13752.

PMID:
31570453
26.

Editorial for the special issue on enzyme assay of amino acids.

Asano Y.

Anal Biochem. 2019 Dec 15;587:113464. doi: 10.1016/j.ab.2019.113464. Epub 2019 Sep 28. No abstract available.

PMID:
31568743
27.

Development of a rapid and simple glycine analysis method using a stable glycine oxidase mutant.

Tatsumi M, Hoshino W, Kodama Y, Ueatrongchit T, Takahashi K, Yamaguchi H, Tagami U, Miyano H, Asano Y, Mizukoshi T.

Anal Biochem. 2019 Dec 15;587:113447. doi: 10.1016/j.ab.2019.113447. Epub 2019 Sep 25.

PMID:
31562850
28.

Stabilization of Hydroxynitrile Lyases from Two Variants of Passion Fruit, Passiflora edulis Sims and Passiflora edulis Forma flavicarpa, by C-Terminal Truncation.

Nuylert A, Motojima F, Khanongnuch C, Hongpattarakere T, Asano Y.

Chembiochem. 2020 Jan 15;21(1-2):181-189. doi: 10.1002/cbic.201900468. Epub 2019 Dec 3.

PMID:
31562666
29.

Sorafenib inhibits vascular endothelial cell proliferation stimulated by anaplastic thyroid cancer cells regardless of BRAF mutation status.

Ishihara S, Onoda N, Noda S, Asano Y, Tauchi Y, Morisaki T, Kashiwagi S, Takashima T, Ohira M.

Int J Oncol. 2019 Nov;55(5):1069-1076. doi: 10.3892/ijo.2019.4881. Epub 2019 Sep 19.

30.

The Gut Microbiome Derived From Anorexia Nervosa Patients Impairs Weight Gain and Behavioral Performance in Female Mice.

Hata T, Miyata N, Takakura S, Yoshihara K, Asano Y, Kimura-Todani T, Yamashita M, Zhang XT, Watanabe N, Mikami K, Koga Y, Sudo N.

Endocrinology. 2019 Oct 1;160(10):2441-2452. doi: 10.1210/en.2019-00408.

PMID:
31504398
31.

Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti-topoisomerase I-positive systemic sclerosis-associated interstitial lung disease.

Ebata S, Yoshizaki A, Fukasawa T, Miura S, Takahashi T, Sumida H, Asano Y, Sato S.

J Dermatol. 2019 Nov;46(11):1006-1013. doi: 10.1111/1346-8138.15079. Epub 2019 Sep 9.

PMID:
31502326
32.

Acupuncture for Chronic Constipation in Patients with Chronic Disorders of Consciousness After Severe Traumatic Brain Injury.

Matsumoto-Miyazaki J, Asano Y, Takei H, Ikegame Y, Shinoda J.

Med Acupunct. 2019 Aug 1;31(4):218-223. doi: 10.1089/acu.2019.1361. Epub 2019 Aug 19.

33.

Continuous intraoperative neuromonitoring for thyroid cancer surgery: A prospective study.

Onoda N, Noda S, Tauchi Y, Asano Y, Kusunoki Y, Ishihara S, Morisaki T, Kashiwagi S, Takashima T, Ohira M.

Laryngoscope Investig Otolaryngol. 2019 Jul 18;4(4):455-459. doi: 10.1002/lio2.290. eCollection 2019 Aug.

34.

Cutaneous phaeohyphomycosis caused by Alternaria alternata in an immunosuppressed patient.

Suda K, Yamashita T, Kawase Y, Yarita K, Yoshizaki A, Akamata K, Asano Y, Kamei K, Sato S.

J Dermatol. 2019 Dec;46(12):e448-e449. doi: 10.1111/1346-8138.15041. Epub 2019 Aug 20. No abstract available.

PMID:
31432527
35.

Functional D-box sequences reset the circadian clock and drive mRNA rhythms.

Yoshitane H, Asano Y, Sagami A, Sakai S, Suzuki Y, Okamura H, Iwasaki W, Ozaki H, Fukada Y.

Commun Biol. 2019 Aug 8;2:300. doi: 10.1038/s42003-019-0522-3. eCollection 2019.

36.

Pure Mucinous Breast Carcinoma with Micropapillary Pattern (MUMPC): A Case Report.

Asano Y, Kashiwagi S, Nagamori M, Tanaka S, Kuwae Y, Amano R, Takashima T, Ohsawa M, Hirakawa K, Ohira M.

Case Rep Oncol. 2019 Jul 16;12(2):554-559. doi: 10.1159/000501766. eCollection 2019 May-Aug.

37.

Usefulness of positron emission tomography for differentiating gliomas according to the 2016 World Health Organization classification of tumors of the central nervous system.

Takei H, Shinoda J, Ikuta S, Maruyama T, Muragaki Y, Kawasaki T, Ikegame Y, Okada M, Ito T, Asano Y, Yokoyama K, Nakayama N, Yano H, Iwama T.

J Neurosurg. 2019 Aug 16:1-10. doi: 10.3171/2019.5.JNS19780. [Epub ahead of print]

PMID:
31419796
38.

Next-generation sequencing identifies contribution of both class I and II HLA genes on susceptibility of multiple sclerosis in Japanese.

Ogawa K, Okuno T, Hosomichi K, Hosokawa A, Hirata J, Suzuki K, Sakaue S, Kinoshita M, Asano Y, Miyamoto K, Inoue I, Kusunoki S, Okada Y, Mochizuki H.

J Neuroinflammation. 2019 Aug 5;16(1):162. doi: 10.1186/s12974-019-1551-z.

39.

A molecular triage process mediated by RING finger protein 126 and BCL2-associated athanogene 6 regulates degradation of G0/G1 switch gene 2.

Kamikubo K, Kato H, Kioka H, Yamazaki S, Tsukamoto O, Nishida Y, Asano Y, Imamura H, Kawahara H, Shintani Y, Takashima S.

J Biol Chem. 2019 Oct 4;294(40):14562-14573. doi: 10.1074/jbc.RA119.008544. Epub 2019 Aug 1.

PMID:
31371451
40.

Thrombocytosis as a prognostic factor in polymyalgia rheumatica: characteristics determined from cluster analysis.

Hayashi K, Ohashi K, Watanabe H, Sada KE, Shidahara K, Asano Y, Asano SH, Yamamura Y, Miyawaki Y, Morishita M, Matsumoto Y, Kawabata T, Wada J.

Ther Adv Musculoskelet Dis. 2019 Jul 18;11:1759720X19864822. doi: 10.1177/1759720X19864822. eCollection 2019.

41.

The Effects of Eribulin on Breast Cancer Microenvironment Identified Using Eribulin-resistant Breast Cancer Cell Lines.

Goto W, Kashiwagi S, Asano Y, Takada K, Takahashi K, Fujita H, Takashima T, Shibutani M, Amano R, Tomita S, Hirakawa K, Ohira M.

Anticancer Res. 2019 Aug;39(8):4031-4041. doi: 10.21873/anticanres.13559.

PMID:
31366485
42.

Treatment With Cyclosporine A for Statin-Naïve Anti-HMGCR Antibody-Associated Necrotizing Myopathy.

Morishima R, Matsubara S, Sugaya K, Bokuda K, Tobisawa S, Asano Y, Miyamoto K, Isozaki E.

J Clin Rheumatol. 2019 Aug;25(5):e72-e73. doi: 10.1097/RHU.0000000000000922. No abstract available.

PMID:
31344002
43.

Risk factors for cytomegalovirus infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis.

Morishita M, Sada KE, Matsumoto Y, Hayashi K, Asano Y, Hiramatsu Asano S, Ohashi K, Miyawaki Y, Katsuyama E, Watanabe H, Kawabata T, Wada J.

PLoS One. 2019 Jul 10;14(7):e0218705. doi: 10.1371/journal.pone.0218705. eCollection 2019.

44.

Moraxella species: infectious microbes identified by use of time-of-flight mass spectrometry.

Takahashi S, Murata K, Ozawa K, Yamada H, Kawakami H, Nakayama A, Asano Y, Mochizuki K, Mikamo H.

Jpn J Ophthalmol. 2019 Jul;63(4):328-336. doi: 10.1007/s10384-019-00669-4. Epub 2019 Jul 4.

PMID:
31273564
45.

A case of scleroderma en coup de sabre with ipsilateral hearing loss and aphakia.

Miura S, Someya M, Toyama S, Kawai T, Yamashita T, Shishido N, Sato S, Asano Y.

Eur J Dermatol. 2019 Aug 1;29(4):423-425. doi: 10.1684/ejd.2019.3572. No abstract available.

PMID:
31251214
46.

Unique correlation profile of adiponectin and retinol-binding protein 4 in patients with systemic sclerosis.

Asano Y, Masui Y, Toyama T, Sato S.

J Dermatol. 2019 Sep;46(9):819-820. doi: 10.1111/1346-8138.14994. Epub 2019 Jun 27. No abstract available.

PMID:
31245857
47.

Verification of the effects of calcium channel blockers on the immune microenvironment of breast cancer.

Takada K, Kashiwagi S, Asano Y, Goto W, Takahashi K, Fujita H, Takashima T, Tomita S, Hirakawa K, Ohira M.

BMC Cancer. 2019 Jun 24;19(1):615. doi: 10.1186/s12885-019-5828-5.

48.

Mouse skeletal muscle creatine chemical exchange saturation transfer (CrCEST) imaging at 11.7T MRI.

Takahashi Y, Saito S, Kioka H, Araki R, Asano Y, Takashima S, Sakata Y, Yoshioka Y.

J Magn Reson Imaging. 2020 Feb;51(2):563-570. doi: 10.1002/jmri.26844. Epub 2019 Jun 22.

PMID:
31228359
49.

Purification, characterization, and gene cloning of a novel aminoacylase from Burkholderia sp. strain LP5_18B that efficiently catalyzes the synthesis of N-lauroyl-l-amino acids.

Takakura Y, Asano Y.

Biosci Biotechnol Biochem. 2019 Oct;83(10):1964-1973. doi: 10.1080/09168451.2019.1630255. Epub 2019 Jun 14.

PMID:
31200632
50.

Prognostic Value of Quality of Life in Endocrine Therapy for Elderly Patients With Breast Cancer: A Retrospective Study.

Takada K, Kashiwagi S, Asano Y, Goto W, Takahashi K, Shibutani M, Amano R, Takashima T, Tomita S, Hirakawa K, Ohira M.

Anticancer Res. 2019 Jun;39(6):2941-2950. doi: 10.21873/anticanres.13424.

PMID:
31177133

Supplemental Content

Support Center